ImmPro

ImmPro is the industry leader in top-down proteomics solutions for biopharmaceutical development. Using our proprietary ProteoSight™ platform, we provide the most comprehensive, single-particle analysis of proteins available — delivering insights that conventional methods miss. Our services include intact proteoform characterization, gene therapy vector quality control, and disease-specific biomarker assay development, helping clients improve product quality, accelerate development, and make more confident decisions. Built on 20+ years and $40M of pioneering research, ImmPro is already partnering with leading pharma teams in neurology, oncology, and gene therapy to bring proteoform precision to the forefront of drug development. We’re scaling and actively collaborating with innovators, investors, and researchers who believe the future of medicine lies beyond proteins—in proteoforms.